Merrimack Pharmaceuticals Inc

MERRIMACK
1 Broadway FL 14
Cambridge, MA, 02142-1187  United States
(617) 441-1000
Company Type: Corporation Independent

Merrimack Pharmaceuticals takes a technological approach to fighting cancer. A biopharmaceutical company, Merrimack develops oncology drugs using its proprietary Network Biology technology, which combines biological data and computer-based modeling to discover and develop candidates. In 2015, it received US approval and Taiwan approval of ONIVYDE for the treatment of pancreatic cancer, but it sold that drug to Ipsen in 2017. The firm then owned three key programs, but two of those failed in mid-stage testing. A year after slashing its workforce by 80%, it announced plans to cut another 60% of its staff in 2018. Merrimack traces its roots back to the early 1990s.

Try D&B Hoovers Free

Financial Statements

Financial data as of December 31, 2019 (12 month period) in USD

Annual Revenue 2019
$50.30 million USD

Dun & Bradstreet collects private company financials for more than 23 million companies in over 200 countries. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (All Sites) 72
  • ASSETS (MIL USD) 20
  •  REVENUE (MIL USD) 50.3
  • TICKER SYMBOL MACK
  • Incorporated 1993
  • FISCAL YEAR END DEC

Get in Touch with 126 Contacts and 5 Principals*

A D&B Hoovers Subscription is your foot in the door to Merrimack Pharmaceuticals Inc contact information.
  • Gary Crocker
    Chairman of the Board
  • GARY L CROCKER
    Chairman of the Board
  • JEAN M FRANCHI
    Chief Financial Officer and Treasurer
  • JEFFREY A MUNSIE
    General Counsel and Secretary
See full contact details
Start Your Free Trial

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Merrimack Pharmaceuticals Inc

Merrimack Pharmaceuticals Inc*

126
Contacts
Reach the right people with access to detailed contact information.
5
Principals
See who the company's key decision makers are
9
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.